IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TEANDREA LYNETTE MCDANIEL

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1598494734
CMS profile
11379608
Location
MUSKEGON HEIGHTS, MI

General Payments · PY2022–2024

$3,387.51

  • Reported across 172 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,426.74

55 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Adult Health MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,426.74 55

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $342.68 1
ITI, Inc. $242.55 7
ABBVIE INC. $226.77 16
GlaxoSmithKline, LLC. $224.66 11
Novo Nordisk AS $100.94 5
Lilly USA, LLC $59.96 3
Teva Pharmaceuticals USA, Inc. $54.00 3
Lundbeck LLC $39.72 2
Otsuka America Pharmaceutical, Inc. $36.66 2
Neurocrine BioSciences, Inc. $24.04 1
Xeris Pharmaceuticals, Inc. $21.95 1
Merck Sharp & Dohme Corporation $20.07 1
Tempus AI, Inc $18.45 1
Bayer HealthCare Pharmaceuticals Inc. $14.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $222.24 13
PY2023 $1,738.53 104
PY2024 $1,426.74 55

Payment records · PY2024 (55)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.14 01/05/2024 Food and Beverage Undisputed 01/23/2026 1107626437 CMS
ABBVIE INC. $12.74 01/24/2024 Food and Beverage Undisputed 01/23/2026 1107626439 CMS
ABBVIE INC. $18.46 02/09/2024 Food and Beverage Undisputed 01/23/2026 1107626441 CMS
ABBVIE INC. $22.44 02/23/2024 Food and Beverage Undisputed 01/23/2026 1107626443 CMS
ABBVIE INC. $13.96 03/26/2024 Food and Beverage Undisputed 01/23/2026 1107626445 CMS
ABBVIE INC. $19.26 04/09/2024 Food and Beverage Undisputed 01/23/2026 1107626447 CMS
ABBVIE INC. $17.78 04/10/2024 Food and Beverage Undisputed 01/23/2026 1107626449 CMS
ABBVIE INC. $18.30 05/01/2024 Food and Beverage Undisputed 01/23/2026 1107626451 CMS
ABBVIE INC. $14.61 05/28/2024 Food and Beverage Undisputed 01/23/2026 1107626453 CMS
ABBVIE INC. $3.54 06/05/2024 Food and Beverage Undisputed 01/23/2026 1107626455 CMS
ABBVIE INC. $13.50 06/11/2024 Food and Beverage Undisputed 01/23/2026 1107626457 CMS
ABBVIE INC. $6.08 09/11/2024 Food and Beverage Undisputed 01/23/2026 1107626459 CMS
ABBVIE INC. $14.30 10/10/2024 Food and Beverage Undisputed 01/23/2026 1107626461 CMS
ABBVIE INC. $10.78 10/22/2024 Food and Beverage Undisputed 01/23/2026 1107626463 CMS
ABBVIE INC. $10.56 11/06/2024 Food and Beverage Undisputed 01/23/2026 1107626465 CMS
ABBVIE INC. $12.32 11/26/2024 Food and Beverage Undisputed 01/23/2026 1107626467 CMS
Bayer Healthcare Pharmaceuticals Inc. $14.29 01/11/2024 Food and Beverage Undisputed 01/23/2026 1086328757 CMS
GlaxoSmithKline, LLC. $11.02 01/19/2024 Food and Beverage Undisputed 01/23/2026 1116464144 CMS
GlaxoSmithKline, LLC. $18.97 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116505887 CMS
GlaxoSmithKline, LLC. $9.77 03/22/2024 Food and Beverage Undisputed 01/23/2026 1115961416 CMS
GlaxoSmithKline, LLC. $0.44 03/22/2024 Food and Beverage Undisputed 01/23/2026 1116602091 CMS
GlaxoSmithKline, LLC. $8.02 04/15/2024 Food and Beverage Undisputed 01/23/2026 1115997048 CMS
GlaxoSmithKline, LLC. $9.27 04/29/2024 Food and Beverage Undisputed 01/23/2026 1116387070 CMS
GlaxoSmithKline, LLC. $11.63 06/10/2024 Food and Beverage Undisputed 01/23/2026 1115929104 CMS
GlaxoSmithKline, LLC. $117.43 08/15/2024 Food and Beverage Undisputed 01/23/2026 1116277062 CMS
GlaxoSmithKline, LLC. $16.35 10/08/2024 Food and Beverage Undisputed 01/23/2026 1116637702 CMS
GlaxoSmithKline, LLC. $11.18 10/18/2024 Food and Beverage Undisputed 01/23/2026 1116024113 CMS
GlaxoSmithKline, LLC. $10.58 11/07/2024 Food and Beverage Undisputed 01/23/2026 1116461818 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.21 02/07/2024 Food and Beverage Undisputed 01/23/2026 1143544996 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.26 03/07/2024 Food and Beverage Undisputed 01/23/2026 1143544998 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.64 04/16/2024 Food and Beverage Undisputed 01/23/2026 1143545000 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.63 06/08/2024 Food and Beverage Undisputed 01/23/2026 1143545002 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.74 06/27/2024 Food and Beverage Undisputed 01/23/2026 1143545004 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.43 10/02/2024 Food and Beverage Undisputed 01/23/2026 1143545006 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.64 10/31/2024 Food and Beverage Undisputed 01/23/2026 1143545008 CMS
Lilly USA, LLC $23.14 04/26/2024 Food and Beverage Undisputed 01/23/2026 1135895367 CMS
Lilly USA, LLC $15.51 10/29/2024 Food and Beverage Undisputed 01/23/2026 1135895369 CMS
Lilly USA, LLC $21.31 11/14/2024 Food and Beverage Undisputed 01/23/2026 1135871692 CMS
Lundbeck LLC $15.39 03/05/2024 Food and Beverage Undisputed 01/23/2026 1146058704 CMS
Lundbeck LLC $24.33 06/06/2024 Food and Beverage Undisputed 01/23/2026 1146058706 CMS
Merck Sharp & Dohme LLC $20.07 10/15/2024 Food and Beverage Undisputed 01/23/2026 1141569132 CMS
Neurocrine Biosciences, Inc. $24.04 11/24/2024 Food and Beverage Undisputed 01/23/2026 1150959036 CMS
Novo Nordisk Inc $21.60 04/11/2024 Food and Beverage Undisputed 01/23/2026 1100295330 CMS
Novo Nordisk Inc $19.16 05/14/2024 Food and Beverage Undisputed 01/23/2026 1100288906 CMS
Novo Nordisk Inc $19.91 05/16/2024 Food and Beverage Undisputed 01/23/2026 1100229770 CMS
Novo Nordisk Inc $17.66 06/04/2024 Food and Beverage Undisputed 01/23/2026 1100373002 CMS
Novo Nordisk Inc $22.61 11/14/2024 Food and Beverage Undisputed 01/23/2026 1100244343 CMS
Otsuka America Pharmaceutical, Inc. $22.84 04/18/2024 Food and Beverage Undisputed 01/23/2026 1119134042 CMS
Otsuka America Pharmaceutical, Inc. $13.82 05/29/2024 Food and Beverage Undisputed 01/23/2026 1119134044 CMS
Supernus Pharmaceuticals, Inc. $342.68 01/26/2024 Food and Beverage Undisputed 01/23/2026 1147884730 CMS
Tempus AI, Inc $18.45 01/12/2024 Food and Beverage Undisputed 01/23/2026 1150184290 CMS
Teva Pharmaceuticals USA, Inc. $18.13 03/26/2024 Food and Beverage Undisputed 01/23/2026 1151677357 CMS
Teva Pharmaceuticals USA, Inc. $18.74 10/31/2024 Food and Beverage Undisputed 01/23/2026 1151677522 CMS
Teva Pharmaceuticals USA, Inc. $17.13 11/19/2024 Food and Beverage Undisputed 01/23/2026 1151677541 CMS
Xeris Pharmaceuticals, Inc. $21.95 05/02/2024 Food and Beverage Undisputed 01/23/2026 1144639826 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.